Abeona Therapeutics (ABEO)

• Market cap: $280M
• 1 day: -0.55%
• 5 days: 1.67%
• 1 month: -0.18%
• 3 months: -18.96%
• 6 months: 11.18%
• Year to date: -7.45%
• 1 year: -16.49%
• 5 years: -82.35%
• 10 years: -94.24%
• Sector: Healthcare
• Industry: Biotechnology

About: Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Employees: 136